VisCardia, a privately held medical device developer in Portland, Oregon, has been developing preclinical and feasibility evidence for its proprietary Asymptomatic Diaphragmatic Stimulation, culminating in the VisOne implantable system.

Leadership

Peter Bauer

Peter Bauer, Ph.D.

President & CEO

Peter is the President and CEO of VisCardia. He most recently served as President of Inovise Medical, after leading as its EVP of R&D. He previously held various leadership positions at BIOTRONIK focused on research and technology in their cardiac rhythm management division.

Ed Chinchoy

Ed Chinchoy, Ph.D.

Executive Vice President

Ed leads strategy and commercialization for VisCardia. He previously served in various leadership roles at St. Jude Medical (Abbott) and Medtronic in both R&D and global commercial roles, and led the multinational commercialization of several novel therapies and medical device platforms for cardiac rhythm management, heart failure therapy and monitoring.

Michael Mirro

Michael Mirro, M.D.

Medical Affairs

Mike has pioneered implantable medical device development as a renowned physician investigator for over 35 years. He is board certified in internal medicine, cardiovascular disease, cardiac electrophysiology, and geriatrics, and has served as a principal investigator for over 100 clinical trials, and as a clinical advisor for multiple medical technology companies.

On Our Team

Alan Andreson

Alan Andreson

Program Strategy and Management
Patti Arand

Patti Arand, Ph.D.

Research
Martin Baumer

Martin Baumer

Engineering
Jack Cheng

Jack Cheng

Development
Carla Donaca

Carla Donaca

Accounting
Ronak Pantagé

Ronak Pantagé

Quality
Jay Snell

Jay Snell

Development
Tim Wheeler

Tim Wheeler

Clinical Operations

Clinical Advisors

John Cleland, M.D.
Professor of Cardiology at Imperial College London and Director of the Robertson Centre for Biostatistics in Glasgow. Former chairman of the British Society for Heart Failure and of the Working Group on Heart Failure of the ESC, and founder of the European Journal of Heart Failure.
Paul Erne, M.D.
Professor Emeritus at the University Hospital of Basel and researcher at the Universita della Svizzera Italiana, Switzerland. He was previously Professor of Cardiology and Specialized Medicine and led the Cardiac Physiology research team at the University Hospital of Basel.
Michael J Mirro, M.D.
Senior Vice President and Chief Academic Research Officer at Parkview Health, Director of the Mirro Center for Research and Innovation at Parkview, and Clinical Professor of Medicine at Indiana University.
Michel Zuber, M.D.
Professor of Cardiology and Internal Medicine at the University Hospital of Zurich, Switzerland, specializing in diagnostic, advanced and interventional echocardiography, with a clinic for non-invasive cardiology and implantable arrhythmia and heart failure devices.

Board of Directors

Peter Bauer

Peter Bauer, Ph.D.

Board Member

Peter is the President and CEO of VisCardia. He most recently served as President of Inovise Medical, after leading as its EVP of R&D. He previously held various leadership positions at BIOTRONIK focused on research and technology in their cardiac rhythm management division.

David Chazanovitz

David Chazanovitz

Chairman of the Board

Dave is the Chairman of the Board for VisCardia, most recently serving as the Chairman of the Board of Inovise Medical, and President and CEO of Alveolus. He previously served as President and CEO of Cambridge Heart, and President of several divisions of C.R. Bard.

Dallas Ross

Dallas Ross

Board Member

Dallas Ross is a GP and founder of Kinetic Capital Partners in Vancouver BC which holds control positions in several private US high growth medical and software companies. He is active on the Board of each of Kinetic’s private companies and several other substantial public companies with operations in the US and Canada. Prior to Kinetic, Mr. Ross was an investment banker in Toronto and Vancouver.